Characteristics and outcome of patients with brain metastases from colorectal cancer
Neuro-Oncology Practice · 09.10.2025 · 12 (5) · 873-883
DOI: 10.1093/nop/npaf040 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuro-Oncology Practice, online erschienen am 17.04.2025. Verfasst von Robin van den Borg und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Amsterdam UMC, Cancer Center Amsterdam, Amsterdam, The Netherlands. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Despite a generally poor prognosis of patients with brain metastases of colorectal cancer (CRC-BM), local treatment of BM might be beneficial in selected patients. The aim of this study was to characterize patient and clinicopathological characteristics of CRC-BM and to identify patients who benefit most from local treatment of CRC-BM.
Methods
In this retrospective cohort study, clinicopathological characteristics, including treatment response and survival, were collected from 100 patients who were treated for CRC-BM at the Netherlands Cancer Institute between 2001 and 2021. All analyses were performed using SPSS.
Results
Median overall survival (OS) from CRC diagnosis and diagnosis of BM was 47.3 and 5.2 months, respectively. Median brain metastasis-free interval (BMFI) was 39.0 months. Median OS of patients with metachronous extracranial metastases (ECM) and subsequent BM was 5.7 months compared to 2.8 months in patients with synchronous ECM and subsequent BM (P = .08). In the latter group, the diameter of BM and liver metastases negatively influenced survival. OS of patients with CRC-BM improved over time (9.0 vs 4.0 months in 2016-2021 vs 2001-2015, respectively (P = .002)) and was better in patients able to receive systemic therapy after diagnosis of CRC-BM compared to patients who did not (19.4 months vs 4.7 months; P = .005).
Conclusions
Although the development of BM in patients with CRC is a late event resulting in a poor prognosis, outcome improved over time. OS was significantly longer in patients who still have systemic treatment options. This can be taken into account in the decision for local treatment of patients with CRC-BM.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Oncology, Amsterdam UMC, Cancer Center Amsterdam, Amsterdam, The Netherlands.
- Department of Gastrointestinal Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
- Department of Neuro-oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
ORCID-Profile: Dieta Brandsma, Tineke E Buffart
Zitieren
APA
van den Borg, R., Kuhlmann, S. L., Brandsma, D., & Buffart, T. E. (2025). Characteristics and outcome of patients with brain metastases from colorectal cancer. Neuro-Oncology Practice, 12(5), 873-883. https://doi.org/10.1093/nop/npaf040
Vancouver
van den Borg R, Kuhlmann SL, Brandsma D, Buffart TE. Characteristics and outcome of patients with brain metastases from colorectal cancer. Neuro-Oncology Practice. 2025;12(5):873-883. doi:10.1093/nop/npaf040
BibTeX
@article{vandenBorg2025,
author = {van den Borg, Robin and Kuhlmann, Sophie L and Brandsma, Dieta and Buffart, Tineke E},
title = {Characteristics and outcome of patients with brain metastases from colorectal cancer},
journal = {Neuro-Oncology Practice},
year = {2025},
volume = {12},
number = {5},
pages = {873--883},
doi = {10.1093/nop/npaf040}
}
EUVIMED